Funding
← Back to your selection

Kadmos Capital

Activity from announced rounds

Activity in this selectionOct 24, 2026 · Healthtech · Jan 1, 2026
Rounds participated in
2
Confirmed lead rounds
0
All roles disclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$9.3M
1 disclosed · full round size, not this investor’s share

By stage

Seed1
Series A1

By primary sector

Healthtech2

By country

Switzerland1
United Kingdom1

Rounds

2 in this selection
Aeon

Preventive health check-ups that combine whole-body MRI, blood biomarkers and medical interpretation to give people a broader view of their health risks.

UndisclosedSeed extension
Participant
Antiverse

Antiverse designs therapeutic antibodies for difficult drug targets using generative AI, engineered cell lines and in-house laboratory testing.

$9.3MSeries A
Participant